Author
Listed:
- Olufunke Fasawe
- Carlos Avila
- Nathan Shaffer
- Erik Schouten
- Frank Chimbwandira
- David Hoos
- Olive Nakakeeto
- Paul De Lay
Abstract
Background: The Ministry of Health in Malawi is implementing a pragmatic and innovative approach for the management of all HIV-infected pregnant women, termed Option B+, which consists of providing life-long antiretroviral treatment, regardless of their CD4 count or clinical stage. Our objective was to determine if Option B+ represents a cost-effective option. Methods: A decision model simulates the disease progression of a cohort of HIV-infected pregnant women receiving prophylaxis and antiretroviral therapy, and estimates the number of paediatric infections averted and maternal life years gained over a ten-year time horizon. We assess the cost-effectiveness from the Ministry of Health perspective while taking into account the practical realities of implementing ART services in Malawi. Results: If implemented as recommended by the World Health Organization, options A, B and B+ are equivalent in preventing new infant infections, yielding cost effectiveness ratios between US$ 37 and US$ 69 per disability adjusted life year averted in children. However, when the three options are compared to the current practice, the provision of antiretroviral therapy to all mothers (Option B+) not only prevents infant infections, but also improves the ten-year survival in mothers more than four-fold. This translates into saving more than 250,000 maternal life years, as compared to mothers receiving only Option A or B, with savings of 153,000 and 172,000 life years respectively. Option B+ also yields favourable incremental cost effectiveness ratios (ICER) of US$ 455 per life year gained over the current practice. Conclusion: In Malawi, Option B+ represents a favorable policy option from a cost-effectiveness perspective to prevent future infant infections, save mothers' lives and reduce orphanhood. Although Option B+ would require more financial resources initially, it would save societal resources in the long-term and represents a strategic option to simplify and integrate HIV services into maternal, newborn and child health programmes.
Suggested Citation
Olufunke Fasawe & Carlos Avila & Nathan Shaffer & Erik Schouten & Frank Chimbwandira & David Hoos & Olive Nakakeeto & Paul De Lay, 2013.
"Cost-Effectiveness Analysis of Option B+ for HIV Prevention and Treatment of Mothers and Children in Malawi,"
PLOS ONE, Public Library of Science, vol. 8(3), pages 1-10, March.
Handle:
RePEc:plo:pone00:0057778
DOI: 10.1371/journal.pone.0057778
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Monique Abimpaye & Catherine M Kirk & Hari S Iyer & Neil Gupta & Eric Remera & Placidie Mugwaneza & Michael R Law, 2018.
"The impact of “Option B” on HIV transmission from mother to child in Rwanda: An interrupted time series analysis,"
PLOS ONE, Public Library of Science, vol. 13(2), pages 1-7, February.
- Masiano, Steven P. & Kawende, Bienvenu & Ravelomanana, Noro Lantoniaina Rosa & Green, Tiffany L. & Dahman, Bassam & Thirumurthy, Harsha & Kimmel, April D. & Yotebieng, Marcel, 2023.
"Economic costs and cost-effectiveness of conditional cash transfers for the uptake of services for the prevention of vertical HIV transmissions in a resource-limited setting,"
Social Science & Medicine, Elsevier, vol. 320(C).
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0057778. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.